Tarsus Pharmaceuticals, Inc. (TARS)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 36.85 |
| Open | 37.00 |
| Bid | 37.04 x 200 |
| Ask | 37.26 x 100 |
| Day's range | 36.35 - 37.85 |
| 52-week range | 12.57 - 40.40 |
| Volume | |
| Avg. volume | 695,873 |
| Market cap | 1.399B |
| Beta (5Y monthly) | 1.05 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Does Tarsus Pharmaceuticals (TARS) Have the Potential to Rally 38.7% as Wall Street Analysts Expect?
The consensus price target hints at a 38.7% upside potential for Tarsus Pharmaceuticals (TARS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- Simply Wall St.
Insider Returns Down To US$166k As Tarsus Pharmaceuticals' Stock Dips 14%
Insiders who bought Tarsus Pharmaceuticals, Inc. ( NASDAQ:TARS ) stock lover the last 12 months are probably not as...
- Zacks
Wall Street Analysts Predict a 47.12% Upside in Tarsus Pharmaceuticals (TARS): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 47.1% in Tarsus Pharmaceuticals (TARS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
© 2024 Yahoo. All rights reserved.